HealthEquity, Inc.
HealthcareNASDAQ:HQY · NASDAQ Global Select
-$0.78 today
Vol 0.71M · Avg 0.99M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $215.2M +122.5% | $96.7M +73.6% | $55.7M +313.1% | -$26.1M +41.0% | -$44.3M | $498.8M | $487.6M | $476.4M |
| Depreciation & Amortization | $154.7M -4.8% | $162.5M +6.1% | $153.1M -5.0% | $161.2M +17.5% | $137.2M | $1.2B | $374.2M | $1.2B |
| Deferred Income Tax | $39.7M +409.5% | -$12.8M +8.3% | -$14.0M +18.5% | -$17.2M +26.7% | -$23.4M | $1.2B | $1.4B | -$1.5B |
| Stock-Based Compensation | $73.1M -24.2% | $96.4M +25.0% | $77.2M +23.2% | $62.6M +18.7% | $52.8M | $623.4M | $489.0M | $354.6M |
| Change in Working Capital | -$26.6M -307.6% | -$6.5M +80.3% | -$33.1M +0.7% | -$33.4M -2153.5% | $1.6M | $484.8M | $350.4M | -$1.6B |
| Accounts Receivables | -$5.7M +56.6% | -$13.1M -62.7% | -$8.1M +15.8% | -$9.6M +14.6% | -$11.2M | $1.3B | $592.6M | $1.3B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $854.4M | $1.0B | $1.2B |
| Accounts Payables | $1.7M -80.8% | $8.9M +4456.9% | -$204.0K +99.2% | -$26.7M -1124.7% | -$2.2M | $657.0M | $948.2M | -$1.5B |
| Other Working Capital | -$22.6M -882.1% | -$2.3M +90.7% | -$24.9M -965.5% | $2.9M -80.9% | $15.0M | $1.3B | $567.4M | $1.3B |
| Other Non-Cash Items | $1.1M -70.8% | $3.6M -9.1% | $4.0M +13.6% | $3.5M -79.4% | $17.2M | $1.2B | $1.4B | -$1.5B |
| Operating Cash Flow | $457.1M +34.5% | $339.9M +40.0% | $242.8M +61.2% | $150.7M +6.8% | $141.0M | $5.5B | $7.2B | $8.9B |
| Capital Expenditures | -$2.0M +5.5% | -$2.1M +95.5% | -$46.1M +61.3% | -$119.1M +13.1% | -$137.1M | $1.0B | $664.0M | $1.4B |
| Acquisitions (Net) | $0 | $0 | $0 | $0 +100.0% | -$504.5M | $769.0M | $937.0M | $1.1B |
| Purchases of Investments | $0 | $0 | $0 | $0 -100.0% | $128.2M | $578.6M | $444.2M | $1.4B |
| Sales of Investments | $0 | $0 | $0 | $0 -100.0% | $2.4M | $1.0B | $822.2M | $318.2M |
| Other Investing Activities | -$45.2M +91.0% | -$503.4M -1034.2% | -$44.4M | $0 +100.0% | -$128.2M | $862.8M | $616.4M | $370.0M |
| Investing Cash Flow | -$47.1M +90.7% | -$505.5M -997.0% | -$46.1M +61.3% | -$119.1M +81.4% | -$639.2M | $3.1B | $4.8B | $6.4B |
| Debt Repayment | -$100.0M -158.4% | $171.3M +414.9% | -$54.4M -521.4% | -$8.8M +86.5% | -$65.0M | $602.4M | $680.8M | $759.2M |
| Common Stock Issued | $11.4M +21.0% | $9.4M +45.7% | $6.5M -3.2% | $6.7M -98.6% | $466.4M | $610.8M | $778.8M | $946.8M |
| Common Stock Repurchased | -$299.3M -146.3% | -$121.5M | $0 | $0 | $0 | $486.2M | $351.8M | -$1.6B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | -$1.6B | $535.2M | $613.6M |
| Other Financing Activities | $867.0K +153.5% | -$1.6M -287.3% | $865.0K +243.4% | -$603.0K +90.7% | -$6.5M | $720.0M | -$1.6B | $1.3B |
| Financing Cash Flow | -$387.0M -772.2% | $57.6M +222.4% | -$47.0M -1661.1% | -$2.7M -100.7% | $394.9M | $10.5B | $12.2B | $13.9B |
| Effect of Forex Changes | $0 | $0 | $0 | $0 | $0 | $1.4B | $1.3B | $1.1B |
| Net Change in Cash | $23.0M +121.3% | -$108.0M -172.2% | $149.7M +418.9% | $28.9M +127.9% | -$103.4M | -$15.5B | $3.2B | $4.9B |
| Free Cash Flow | $455.1M +34.7% | $337.8M +71.7% | $196.8M +524.2% | $31.5M +705.4% | $3.9M | $14.3B | $8.6B | -$16.8B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
DaVita Inc.
NYSE:DVA
$13.44B
Penumbra, Inc.
NYSE:PEN
$12.53B
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
$12.21B
Globus Medical, Inc.
NYSE:GMED
$10.84B
Molina Healthcare, Inc.
NYSE:MOH
$10.44B
Henry Schein, Inc.
NASDAQ:HSIC
$9.31B
Corcept Therapeutics Incorporated
NASDAQ:CORT
$8.94B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.71B
Hims & Hers Health, Inc.
NYSE:HIMS
$5.99B
SEC Filings
Recent regulatory filings
No filings found.
Does HQY generate free cash flow?
HealthEquity, Inc. (HQY) generated $455.13M of free cash flow in fiscal 2026.
How much operating cash flow does HQY produce?
Operating cash flow was $457.09M, before capital expenditures of $1.97M.
Explore More
Continue the stock analysis
Jump to another research area for this company.